News Release
Drug Development in China – CHI Pharmaceutical Strategy Series
- Title :Drug Development in China – CHI Pharmaceutical Strategy Series
- Date :Oct 31, 2006
- Location :San Francisco, CA, USA
- Description :Dr. Ying Luo, CEO of Shanghai Genomics and COO of GNI, presents at the “Drug Development in China – Strategies for Launching Discovery and Development Activities” in San Francisco, California. The meeting is part of the CHI Pharmaceutical Strategy Series. His talk focuses on the need to build a balance product pipeline in China.